#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myeloproliferative neoplasm Fontan procedure Mucous membrane pemphigoid Polycythaemia vera Burkitt's lymphoma Anti-neutrophil cytoplasmic antibody positive vasculitis Spinal cord injury cervical Adult T-cell lymphoma/leukaemia refractory Small for dates baby Becker's muscular dystrophy Fabry's disease Hypersomnia Pouchitis Haemolytic uraemic syndrome Osteogenesis imperfecta More trials…

    Learn about Rare Diseases

    Haemolytic uraemic syndrome – Life with Disease Lennox-Gastaut syndrome – Treatment IgA nephropathy – Basic Information Pemphigoid – Trials in Disease Behcet’s syndrome – Basic Information Lymphatic malformation – Basic Information Glomerulonephritis membranous – Life with Disease Leiomyosarcoma metastatic – Diagnostics Systemic sclerosis pulmonary – Trials in Disease Pulmonary fibrosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Betula Verrucosa Pollen Elacestrant Naloxone Hydrochloride Cagrilintide Amcenestrant PEGVISOMANT PROMESTRIENE Seralutinib Human Coagulation Factor Ix Lecanemab Gskvx000000008866 Aldesleukin Fenebrutinib Air, Medicinal Sodium Fluoride (18F) HYDROXYCHLOROQUINE Resiniferatoxin Glatiramer Acetate INF904 Pamapimod More therapies…

    Learn about Your Condition

    Aplastic anaemia Paedophilia Ankylosing spondylitis Agitation postoperative Double hit lymphoma Embolic stroke Osteoporosis postmenopausal Haemoptysis Prostate cancer recurrent Gender dysphoria Nephrogenic anaemia Skin candida Colonoscopy Papillary thyroid cancer Poor quality sleep More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Huntington’s disease

  • Study on [18F]MNI-659 to Track Huntington’s Disease Progression in Symptomatic and Pre-symptomatic Patients

    Recruiting

    3 1 1
    Investigated Drugs:
    • 2-[2-[3-[4-(2-(18F)FLUORANYLETHOXY)PHENYL]-7-METHYL-4-OXOQUINAZOLIN-2-YL]ETHYL]-4-PROPAN-2-YLOXYISOINDOLE-1,3-DIONE
    France

  • Study on the Safety of VO659 for Patients with Spinocerebellar Ataxia Types 1, 3, and Huntington’s Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Hereditary ataxia
    • Huntington’s disease
    Investigated Drugs:
    • Vo659
    Denmark France Germany The Netherlands

  • Study on the Use of Thiamine and Biotin for Patients with Huntington’s Disease

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Huntington’s disease
    Investigated Drugs:
    • Biotin
    • Thiamine
    Spain

  • Efficacy and safety of votoplam in adults with Huntington’s disease: a randomized, double‑blind, placebo‑controlled Phase 3 trial

    Recruiting

    3 1
    Investigated Drugs:
    • VOTOPLAM
    Austria Belgium Bulgaria Czechia Denmark Finland +14

  • Phase 2/3 Randomized Study of SKY-0515 for Safety and Efficacy in Adults with Huntington’s Disease

    Not yet recruiting

    4 1
    Germany Spain

  • Study on the Effects of Metformin on Cognitive Function in Patients with Huntington’s Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Huntington’s disease
    Investigated Drugs:
    • Metformin Hydrochloride
    Spain
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!